Connacht Asset Management »

United Therapeutics Corporation shares owned by Connacht Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Connacht Asset Management from 13F filings

Historical chart of Connacht Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Connacht Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Connacht Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $306k 1.4k 225.87
2023-06-30 $593k 2.7k 220.75
2023-03-31 $458k 2.0k 223.96
2022-12-31 $406k 1.5k 278.09
2022-09-30 $416k 2.0k 209.36
2022-06-30 $1.7M 7.4k 235.64

More positions owned by Connacht Asset Management

Casella Waste Sys Cl A (CWST)
Axon Enterprise (AXON)
Colfax Corp (ENOV)
Northern Oil And Gas Inc Mn (NOG)
WESCO International (WCC)
Air Transport Services (ATSG)
Chefs Whse (CHEF)
Mp Materials Corp Com Cl A (MP)
Digitalbridge Group Cl A New (DBRG)
Universal Display Corporation (OLED)
Bausch Plus Lomb Corp Common Shares (BLCO)
Callaway Golf Company (MODG)
Sonos (SONO)
Timken Company (TKR)
East West Ban (EWBC)

View all positions for Connacht Asset Management

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
AQR Capital Management
LSV Asset Management
Bank of New York Mellon
Norges Bank Investment Management
Charles Schwab Investment Management
Palo Alto Investors
OrbiMed Advisors
Pacer Advisors
Nordea Investment Management Ab
Caisse de depot et placement du Quebec

View all funds holding United Therapeutics Corporation